Parameter | Sex | Reference range | Group | Ingestion period | Follow-up period | |||
---|---|---|---|---|---|---|---|---|
0 w | 4 w | 8 w | 12 w | 16 w | ||||
WBC (/μL) | 3500-9700 | A | 6090.1 (157.0) | 6423.4 (183.2)** | 6188.5 (166.2) | 6298.6 (188.2) | 6288.3 (156.4)* | |
P | 5986.3 (143.3) | 6094.6 (157.6) | 6011.3 (143.5) | 6108.6 (156.2) | 6230.1 (153.6)* | |||
RBC (×104/μL) | M | 438-577 | A | 491.9 (4.7)# | 489.2 (4.7) | 487.6 (4.5)* | 489.7 (5.1) | 495.0 (4.8) |
P | 507.8 (4.6) | 498.6 (4.8)** | 500.2 (4.5)** | 500.1 (4.8)** | 504.1 (4.9) | |||
F | 376-516 | A | 449.4 (4.2) | 446.7 (4.5) | 445.7 (4.2) | 449.2 (4.3) | 451.6 (4.4) | |
P | 447.3 (4.4) | 444.8 (4.8) | 446.8 (4.8) | 447.1 (4.7) | 452.6 (4.4)* | |||
Hb (g/dL) | M | 13.6-18.3 | A | 15.25 (0.13) | 15.20 (0.14) | 15.18 (0.14) | 15.26 (0.17) | 15.44 (0.14)* |
P | 15.51 (0.13) | 15.24 (0.14)** | 15.34 (0.13)* | 15.32 (0.14)* | 15.43 (0.14) | |||
F | 11.2-15.2 | A | 13.36 (0.14) | 13.34 (0.14) | 13.33 (0.14) | 13.41 (0.14) | 13.50 (0.14)* | |
P | 13.44 (0.14) | 13.38 (0.15) | 13.44 (0.15) | 13.44 (0.14) | 13.60 (0.13)* | |||
Ht (%) | M | 40.4-51.9 | A | 45.67 (0.39) | 45.59 (0.44) | 44.89 (0.43)** | 45.06 (0.51) | 45.66 (0.41) |
P | 46.46 (0.38) | 45.96 (0.42)* | 45.12 (0.40)** | 45.35 (0.33)** | 45.60 (0.39)** | |||
F | 34.3-45.2 | A | 41.32 (0.36) | 40.91 (0.38) | 40.66 (0.38)** | 40.57 (0.31)** | 40.81 (0.36)* | |
P | 41.38 (0.39) | 41.00 (0.42) | 40.84 (0.43)** | 40.63 (0.39)** | 41.17 (0.37) | |||
Plt (×104/μL) | 14.0-37.9 | A | 25.95 (0.54) | 26.06 (0.58) | 26.02 (0.54) | 25.94 (0.55) | 26.74 (0.55)** | |
P | 26.33 (0.59) | 26.62 (0.60) | 26.67 (0.63) | 26.64 (0.59) | 27.15 (0.61)** |